Attached files
| file | filename |
|---|---|
| 10-K - ZIOPHARM ONCOLOGY INC | v177246_10k.htm |
| EX-23.1 - ZIOPHARM ONCOLOGY INC | v177246_ex23-1.htm |
| EX-33.2 - ZIOPHARM ONCOLOGY INC | v177246_ex32-2.htm |
| EX-31.1 - ZIOPHARM ONCOLOGY INC | v177246_ex31-1.htm |
| EX-31.2 - ZIOPHARM ONCOLOGY INC | v177246_ex31-2.htm |
| EX-32.1 - ZIOPHARM ONCOLOGY INC | v177246_ex32-1.htm |
Exhibit
10.16
AMENDMENT
TO
LICENSE
AGREEMENT
BETWEEN
BAXTER
AND
ZIOPHARM
ONCOLOGY, INC.
This
Amendment, effective September 24, 2009 is an Amendment to the License Agreement
dated November 3, 2006, as amended, between Baxter Healthcare S.A. having an
address at Hertistrasse 2, CH-8304, Wallisellen Switzerland and Baxter
International, Inc. having an address at One Baxter Parkway, Deerfield, IL 60015
(collectively, “Baxter”) on the one hand and Ziopharm Oncology, Inc. having an
address at 1 First Avenue, Parris Building # 34, Charlestown, MA 02129
(hereinafter “Licensee”).
WHEREAS,
Baxter and Licensee wish to amend the license grant of the License
Agreement;
NOW,
THEREFORE, in consideration of the mutual agreement hereinafter set forth,
Baxter and Licensee hereby agree to amend the License Agreement as
follows:
Section
2.1 is changed to read as follows:
“2.1 Grant. Subject
to the conditions hereunder,
|
|
(a)
|
Baxter
hereby grants to Licensee a world-wide royalty bearing (pursuant to
Article 3) exclusive right and license, with the right to grant
sublicenses, under Licensed Patents to use, market, sell, offer to sell,
make, have made and import Licensed Products in the Territory;
and
|
|
|
(b)
|
Baxter
hereby grants to Licensee a world-wide, non-royalty bearing exclusive
right and license, with the right to grant sublicenses, under the
Intangible Property Rights to use, market, sell, offer to sell, make, have
made and import Licensed Products in the
Territory.”
|
Article 4
is deleted in its entirety.
In all
other respects, the License Agreement shall remain in full force and effect,
unless further amended by written agreement.
IN
WITNESS WHEREOF, the parties hereto have duly executed this Amendment effective
the day and year first above-written.
ZIOPHARM
ONCOLOGY, INC.
By:
/s/ Richard
Bagley
Name: Richard
Bagley
Title: President, COO,
CFO
| BAXTER HEALTHCARE S.A. | |||
|
|
By:
|
/s/ John W. Cornell | |
| Name: John W. Cornell | |||
| Title: Assistant General Counsel | |||
| BAXTER INTERNATIONAL INC. | |||
| By: | /s/ John W. Cornell | ||
| Name: John W. Cornell | |||
| Title: Assistant General Counsel | |||